TLSIW

TRISALUS LIFE SCIENCES, INC.

TLSIW · CIK 1826667 · Annual (10-K) · Last 4 years

Financial Trends

Revenue$29M
20212024
Net Income−$30M
20212024
Operating CF−$41M
20212024
Free Cash Flow−$41M
20212024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Revenue$0.0B$0.0B——
Cost of Revenue$0.0B$0.0B——
Gross Profit$0.0B$0.0B——
R&D Expense$0.0B$0.0B——
SG&A Expense————
Operating Income$-0.0B$-0.1B$-0.0B$-0.0B
Net Income$-0.0B$-0.1B$0.0B$0.0B
EPS (Basic)$-1.31$-6.73——
EPS (Diluted)$-1.31$-6.73——

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Total Assets$0.0B$0.0B$0.0B$0.3B
Current Assets$0.0B$0.0B$0.0B$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.1B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B—
Stockholders' Equity$-0.0B$-0.0B$-0.0B$-0.0B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Operating Cash Flow$-0.0B$-0.1B$-0.0B$-0.0B
Investing Cash Flow$-0.0B$-0.0B$0.2B$0.0B
Capital Expenditures$0.0B$0.0B——
Financing Cash Flow$0.0B$0.1B$-0.2B$0.0B
← Companies